Titan Pharmaceuticals
TTNP
#10474
Rank
NZ$10.5 M
Marketcap
NZ$7.90
Share price
-3.76%
Change (1 day)
13.93%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.52. In 2023 the company made an earnings per share (EPS) of NZ-$12.69 an increase over its 2022 EPS that were of NZ-$26.02.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.69-51.22%
2022NZ-$26.02-15.61%
2021NZ-$30.84-81.37%
2020NZ-$165.50-77.52%
2019NZ-$736.33-56.32%
2018NZ-$1,686-59.51%
2017NZ-$4,164-371.81%
2016NZ$1,532-144.35%
2015NZ-$3,454300%
2014NZ-$863.46-121.54%
2013NZ$4,009-151.38%
2012NZ-$7,802-11.54%
2011NZ-$8,820188.89%
2010NZ-$3,053-10%
2009NZ-$3,392
2007NZ-$13,908-2.38%
2006NZ-$14,247-39.13%
2005NZ-$23,406-16.87%
2004NZ-$28,155-22.43%
2003NZ-$36,2964.9%
2002NZ-$34,60061.9%
2001NZ-$21,371-13.7%
2000NZ-$24,76365.01%
1999NZ-$15,007-35.87%
1998NZ-$23,402-1824.71%
1997NZ$1,357-102.4%
1996NZ-$56,649

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.08-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.61-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.43-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.05140-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.43-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.79-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA